Coherus Biosciences Inc

UDENYCA

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / UDENYCA – Q5111

Manufacturer:

Coherus Biosciences Inc

Name:

UDENYCA

HCPCS Code Descriptor:

Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg

Category:

Q Code

HCPCS:

Q5111

NDC(s):

70114-0101-01

Primary Type:

Oncology Biosimilar Colony Stimulating Factor

Generic/Specialty Status:

NEULASTA Biosimilar

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

UDENYCA is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Coherus Biosciences Inc and administered via the Subcutaneous route of administration. The Q Code: Q5111 is aligned to the drug UDENYCA.

Udenyca (pegfilgrastim) is an artificial protein that aids the production of white blood cells. It is used to help prevent patients from developing deficiency of these white blood cells. Udenyca is manufactured by Coherus Biosciences and is biosimilar to the drug Neulasta (J2506). Udenyca is aligned to the HCPCS code Q5111 and has been aligned to this code since January 2019. Patient assistance programs for this medication can be found through Coherus Solutions.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

4/1/23

HCPCS Short Description:

Injection, udenyca 0.5 mg

Billing and Coding Guide:

https://www.coherussolutions.com/content/assets/documents/Coding_Ref_Guide_0319_COH_P144r1.pdf

Patient Assistance:

https://www.coherussolutions.com/

UDENYCA - Q5111